ArticleAsian journal of transfusion science
Passenger lymphocyte syndrome: Need for consensus on transfusion guidelines and direct anti-globulin test screening in post-liver transplantation period.
Article in Asian journal of transfusion science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In post-transplant phase, liver transplant (LT) recipients may experience anemia or hemolysis due to various immune or non-immune reasons and require prompt intervention and timely management. One such instance is when recipients of minor ABO-incompatible LT (ABOiLT) experience delayed hemolysis mediated by lymphocytes present in the graft known as passenger lymphocyte syndrome (PLS). We present a case report of a PLS in a 6-month-old child who underwent ABOiLT. On postoperative day 14, there was a drop in patient's hemoglobin, and anti-human globulin crossmatch was incompatible with recipient group (A positive) red cells. No standardized consensus exists on screening for PLS in post-LT recipients. In transplant settings, it is imperative to streamline the workflow for timely recognition and management of PLS early to prevent adverse outcomes and minimize invasive therapy. We present this case of PLS in a post-LT child to highlight the need for right algorithm of immuno-hematological workup in case of post-transplant hemolysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.